JP2019523407A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019523407A5 JP2019523407A5 JP2019502253A JP2019502253A JP2019523407A5 JP 2019523407 A5 JP2019523407 A5 JP 2019523407A5 JP 2019502253 A JP2019502253 A JP 2019502253A JP 2019502253 A JP2019502253 A JP 2019502253A JP 2019523407 A5 JP2019523407 A5 JP 2019523407A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- fluorescence
- binding polypeptide
- flow cytometry
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022084613A JP2022117998A (ja) | 2016-07-21 | 2022-05-24 | Fc結合能を有する融合タンパク質を含む細胞外小胞の使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1612643.5A GB2552473A (en) | 2016-07-21 | 2016-07-21 | Surface decoration of extracellular vesicles |
| GB1612643.5 | 2016-07-21 | ||
| PCT/EP2017/068486 WO2018015539A1 (en) | 2016-07-21 | 2017-07-21 | Uses of extracellular vesicle comprising a fusion protein having fc binding capacity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022084613A Division JP2022117998A (ja) | 2016-07-21 | 2022-05-24 | Fc結合能を有する融合タンパク質を含む細胞外小胞の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019523407A JP2019523407A (ja) | 2019-08-22 |
| JP2019523407A5 true JP2019523407A5 (cg-RX-API-DMAC7.html) | 2022-06-10 |
| JP7140743B2 JP7140743B2 (ja) | 2022-09-21 |
Family
ID=56894359
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019502253A Expired - Fee Related JP7140743B2 (ja) | 2016-07-21 | 2017-07-21 | Fc結合能を有する融合タンパク質を含む細胞外小胞の使用 |
| JP2019502697A Active JP7254016B2 (ja) | 2016-07-21 | 2017-07-21 | Fc結合能力を有する融合タンパク質を含む細胞外小胞 |
| JP2022084613A Pending JP2022117998A (ja) | 2016-07-21 | 2022-05-24 | Fc結合能を有する融合タンパク質を含む細胞外小胞の使用 |
| JP2022192884A Withdrawn JP2023026440A (ja) | 2016-07-21 | 2022-12-01 | Fc結合能力を有する融合タンパク質を含む細胞外小胞 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019502697A Active JP7254016B2 (ja) | 2016-07-21 | 2017-07-21 | Fc結合能力を有する融合タンパク質を含む細胞外小胞 |
| JP2022084613A Pending JP2022117998A (ja) | 2016-07-21 | 2022-05-24 | Fc結合能を有する融合タンパク質を含む細胞外小胞の使用 |
| JP2022192884A Withdrawn JP2023026440A (ja) | 2016-07-21 | 2022-12-01 | Fc結合能力を有する融合タンパク質を含む細胞外小胞 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11236143B2 (cg-RX-API-DMAC7.html) |
| EP (3) | EP4299137A3 (cg-RX-API-DMAC7.html) |
| JP (4) | JP7140743B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102636776B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN109689097B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2017299214A1 (cg-RX-API-DMAC7.html) |
| BR (2) | BR112019001108A2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3031183A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2552473A (cg-RX-API-DMAC7.html) |
| MX (2) | MX2019000863A (cg-RX-API-DMAC7.html) |
| SG (4) | SG10202100598RA (cg-RX-API-DMAC7.html) |
| WO (2) | WO2018015535A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012040623A2 (en) | 2010-09-24 | 2012-03-29 | The Brigham And Women's Hospital, Inc. | Nanostructured gels capable of controlled release of encapsulated agents |
| GB2552774A (en) * | 2016-07-12 | 2018-02-14 | Evox Therapeutics Ltd | EV-Mediated delivery of binding protein-small molecule conjugates |
| GB2552473A (en) * | 2016-07-21 | 2018-01-31 | Evox Therapeutics Ltd | Surface decoration of extracellular vesicles |
| WO2018144991A1 (en) | 2017-02-03 | 2018-08-09 | The Brigham And Women's Hospital, Inc. | Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof |
| GB201702863D0 (en) * | 2017-02-22 | 2017-04-05 | Evox Therapeutics Ltd | Improved loading of EVs with therapeutic proteins |
| WO2019032628A1 (en) | 2017-08-07 | 2019-02-14 | The Regents Of The University Of California | GENERATING PLATFORM FOR SAFE CELLULAR THERAPEUTIC AGENTS |
| GB201717446D0 (en) | 2017-10-24 | 2017-12-06 | Evox Therapeutics Ltd | Affinity purification of engineering extracellular vesicles |
| GB201804291D0 (en) * | 2018-03-16 | 2018-05-02 | Evox Therapeutics Ltd | Cell-mediated exosome delivery |
| US20190307885A1 (en) | 2018-04-04 | 2019-10-10 | Alivio Therapeutics, Inc. | Self-assembled gels for controlled delivery of biologics and methods of making thereof |
| TWI770396B (zh) * | 2018-06-28 | 2022-07-11 | 中央研究院 | 合成多肽及其用途 |
| KR102917499B1 (ko) | 2018-07-20 | 2026-01-26 | 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 | 백혈병 억제 인자 활성을 억제하기 위한 가용성 폴리펩타이드 및 이의 사용 방법 |
| GB201812992D0 (en) | 2018-08-09 | 2018-09-26 | Univ Greenwich | Liposomes |
| BR112021002710A2 (pt) | 2018-08-14 | 2021-11-16 | Evercyte Gmbh | Vesículas extracelulares específicas alvo (tev), uma preparação, uma proteína de superfície da vesícula extracelular específica alvo, um domínio extravesicular específico alvo da mesma. codificação de ácido nucleico, biblioteca de tev, preparação farmacêutica e sua utilização; métodos de produção |
| CN108998402B (zh) * | 2018-08-28 | 2020-05-29 | 江南大学 | 一种重组枯草芽孢杆菌及其构建方法与应用 |
| US20210317479A1 (en) | 2018-09-06 | 2021-10-14 | The Broad Institute, Inc. | Nucleic acid assemblies for use in targeted delivery |
| SG11202103756XA (en) * | 2018-10-19 | 2021-05-28 | Ohio State Innovation Foundation | Extracellular vesicles for targeted therapies against myeloid-derived suppressor cells |
| CN113166267A (zh) | 2018-10-19 | 2021-07-23 | 俄亥俄州国家创新基金会 | 纳米工程化治疗性隐形细胞 |
| JP7577335B2 (ja) | 2018-10-19 | 2024-11-05 | オハイオ・ステイト・イノベーション・ファウンデーション | 肺炎症治療用のナノキャリア |
| CN113301914B (zh) * | 2018-10-25 | 2026-02-03 | 尼希尔有限公司 | 用于治疗和预防纤维化的组合物和方法 |
| CN113272426A (zh) * | 2018-11-16 | 2021-08-17 | 医福斯治疗有限公司 | 用于尿素循环蛋白和核酸的替代的细胞外囊泡 |
| SG11202107007VA (en) * | 2018-12-27 | 2021-07-29 | Akeso Biopharma Inc | Antibody against human il-4ra and use thereof |
| JP2022519275A (ja) * | 2019-02-04 | 2022-03-22 | コディアック バイオサイエンシーズ, インコーポレイテッド | エクソソーム操作のための膜タンパク質足場 |
| US12357704B2 (en) | 2019-05-06 | 2025-07-15 | Thomas Malcolm | Tailored hypoimmune nanovesicular delivery systems for cancer tumors |
| US20220259617A1 (en) * | 2019-06-13 | 2022-08-18 | The General Hospital Corporation | Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells |
| WO2020249757A1 (en) * | 2019-06-14 | 2020-12-17 | Philogen S.P.A | Immunoconjugates comprising a single chain diabody and interleukin-15 or interleukin-15 and a sushi domain of interleukin-15 receptor alpha |
| AU2020298314A1 (en) * | 2019-06-21 | 2022-02-03 | Entelexo Biotherapeutics Inc. | Platforms, compositions, and methods for therapeutics delivery |
| JP7898376B2 (ja) * | 2019-08-06 | 2026-07-31 | オハイオ・ステイト・イノベーション・ファウンデーション | 治療用細胞外小胞 |
| EP3973969A4 (en) * | 2019-09-02 | 2023-07-12 | Kyungpook National University Industry-Academic Cooperation Foundation | COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER USING IL-2 EXTRACELLULAR SURFACE EXPRESSION VESICLES AS AN ACTIVE AGENT |
| CN115942957A (zh) * | 2019-11-04 | 2023-04-07 | 阿鲁纳生物股份公司 | 细胞外囊泡及其用于抗体递送的用途 |
| CN112941028A (zh) * | 2019-12-09 | 2021-06-11 | 上海细胞治疗集团有限公司 | 纳米抗体基因修饰的间充质干细胞及其制备方法与应用 |
| KR20220139926A (ko) | 2020-02-05 | 2022-10-17 | 다이아뎀 바이오쎄라퓨틱스 인크 | 인공 시냅스 |
| WO2021211460A1 (en) * | 2020-04-13 | 2021-10-21 | City Of Hope | Cell-receptor targeted exosomes |
| CN111544453B (zh) * | 2020-04-27 | 2021-01-22 | 高连如 | 一种包含三种血管再生属性的混合干细胞注射液及其制备方法 |
| CN111560352B (zh) * | 2020-06-02 | 2023-03-24 | 新疆农业大学 | 一种病毒样囊泡及其制备方法和应用 |
| CN111905105B (zh) * | 2020-07-02 | 2023-05-05 | 华南师范大学 | 一种用于癌症靶向治疗的蛋白类纳米药物及其制备方法 |
| CN112111513A (zh) * | 2020-07-17 | 2020-12-22 | 深圳市第二人民医院 | 基于外泌体平台的新冠病毒疫苗制备方法 |
| BR112023001272A2 (pt) | 2020-07-24 | 2023-04-04 | Massachusetts Gen Hospital | Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células |
| CN113967254B (zh) * | 2020-08-04 | 2022-08-12 | 华南理工大学 | 用于多特异性抗体递送的细胞膜包覆型纳米适配子及应用 |
| JP2023536665A (ja) * | 2020-08-05 | 2023-08-28 | オハイオ・ステイト・イノベーション・ファウンデーション | アダプターポリペプチドおよびその使用方法 |
| CN112285195B (zh) * | 2020-10-27 | 2021-08-10 | 江南大学 | 一种牛奶外泌体的特征性糖蛋白标志物和牛奶外泌体的特征性标志物分离方法 |
| WO2022149779A1 (ko) * | 2021-01-11 | 2022-07-14 | 주식회사 엑소코바이오 | 과발현된 Fc 수용체 또는 이의 일부를 포함하는 엑소좀 및 이의 제조방법 |
| KR102252325B1 (ko) * | 2021-01-14 | 2021-05-14 | 이장호 | 태아 유래 태초 면역글로불린을 포함하는 세포외소포의 제조방법 |
| WO2022158836A1 (ko) * | 2021-01-21 | 2022-07-28 | 주식회사 엑소코바이오 | 목적 단백질 또는 펩타이드가 융합가능한 Fc 수용체 또는 이의 일부를 포함하는 재조합 엑소좀 및 이의 용도 |
| WO2022219075A2 (en) * | 2021-04-14 | 2022-10-20 | Anjarium Biosciences Ag | Peptides, nanovesicles, and uses thereof for drug delivery |
| EP4323396A1 (en) * | 2021-04-14 | 2024-02-21 | Anjarium Biosciences AG | Fc-derived polypeptides |
| JP2024518732A (ja) * | 2021-04-23 | 2024-05-02 | スポット バイオシステムズ リミテッド | 生体分子がロードされた細胞外小胞 |
| GB202107182D0 (en) * | 2021-05-19 | 2021-06-30 | Evox Therapeutics Ltd | Nanoparticle delivery system for production of engineered extracellular vesicles |
| EP4355304A4 (en) * | 2021-06-17 | 2025-04-30 | Malcolm, Thomas | PERSONALIZED HYPOIMMUNE NANOVESICULAR DELIVERY SYSTEMS FOR CANCERS, INHERITED DISEASES AND INFECTIOUS DISEASES |
| CN115770302A (zh) * | 2021-08-13 | 2023-03-10 | 南京大学 | 一种rna递送系统及其应用 |
| CN113599516B (zh) * | 2021-08-16 | 2022-02-18 | 上海蒙彼利生物技术有限公司 | 制备外泌体方法及其药物组合物在组织修复中的应用 |
| KR102577502B1 (ko) * | 2021-09-08 | 2023-09-13 | 주식회사 꿈랩 | 생체분자의 안정적 발현 및 전달을 위한 플라스미드 플랫폼 |
| CN113897387B (zh) * | 2021-10-09 | 2023-09-05 | 深圳市汉科生命工程有限公司 | 一种具有促进毛发再生功能的基因重组msc及其外泌体样纳米材料的制备方法和应用 |
| WO2023076768A1 (en) * | 2021-10-26 | 2023-05-04 | Navicure Biopharmaceuticals Limited | Combination therapies against cancer and infectious diseases |
| CN116218780A (zh) * | 2021-12-03 | 2023-06-06 | 洪明奇 | 外泌体的生产及其用途 |
| CN114107253B (zh) * | 2021-12-17 | 2024-03-15 | 复旦大学附属华山医院 | 一种利用工程细胞进行基因编辑的系统及方法 |
| CN114236113B (zh) * | 2021-12-21 | 2023-07-21 | 南京农业大学 | 一种2,4-滴的即用型免疫传感器 |
| WO2023133425A1 (en) * | 2022-01-04 | 2023-07-13 | The Broad Institute, Inc. | Compositions and methods for delivering cargo to a target cell |
| WO2023196586A1 (en) * | 2022-04-07 | 2023-10-12 | The Regents Of The University Of Michigan | Methods and devices for screening extracellular vesicles |
| CN116903712A (zh) * | 2022-04-12 | 2023-10-20 | 四川大学华西医院 | 一种人源IgG结合肽及其用途 |
| WO2024064748A2 (en) * | 2022-09-20 | 2024-03-28 | North Carolina State University | Compositions and methods related to exosomal delivery of therapeutic agents |
| CN116179582A (zh) * | 2022-09-27 | 2023-05-30 | 南京医事达生物科技有限公司 | 一种通用型基因重组蛋白质a亲和纯化填料制备方法和应用 |
| CN117802045A (zh) * | 2022-09-30 | 2024-04-02 | 北京恩康医药有限公司 | 一种工程化细胞外囊泡的构建及其应用 |
| CN115873905A (zh) * | 2022-11-15 | 2023-03-31 | 重庆医科大学附属儿童医院 | 一种gd2纳米抗体靶向修饰的类外泌体的新型药物载体的制备方法 |
| KR102929157B1 (ko) | 2023-03-08 | 2026-02-23 | 차이나 메디칼 유니버시티 | 엑소좀의 생산 및 이의 용도 |
| KR20240158824A (ko) * | 2023-04-26 | 2024-11-05 | (주)인엑소플랫 | 면역글로불린 Fc 영역 또는 이의 변이체를 포함하는 재조합 세포외 소포체 및 이를 이용한 세포외 소포체의 분리 방법 |
| KR20240159543A (ko) * | 2023-04-28 | 2024-11-05 | 연세대학교 산학협력단 | 유방암 유래 엑소좀 또는 세포외 소포체 분리 방법 |
| GB202307239D0 (en) | 2023-05-15 | 2023-06-28 | Evox Therapeutics Ltd | Gene therapies for Phenylketonuria |
| CN119120376A (zh) * | 2023-07-10 | 2024-12-13 | 浙江大学医学院附属第一医院 | 一种用于清除致病抗体的嵌合基因工程化纳米囊泡及其制备方法、应用 |
| EP4784736A2 (en) | 2023-09-29 | 2026-08-05 | Evox Therapeutics Limited | Polypeptides comprising inteins for engineered evs |
| WO2025102257A1 (zh) * | 2023-11-15 | 2025-05-22 | 深圳先进技术研究院 | 一种靶向子宫工程化细胞外囊泡的制备方法及其应用 |
| WO2025217863A1 (zh) * | 2024-04-18 | 2025-10-23 | 苏州鲲石一号生物科技有限公司 | Gas6融合蛋白及其制备方法与应用 |
| CN118725135B (zh) * | 2024-09-02 | 2025-02-07 | 中国科学院苏州纳米技术与纳米仿生研究所 | 外泌体的改造方法 |
| CN119019494B (zh) * | 2024-10-28 | 2025-02-07 | 广州飞来爱生命科技有限公司 | 一种治疗心梗的脐带间充质干细胞及其制备方法和应用 |
| GB2702728A (en) | 2024-10-29 | 2026-06-24 | Evox Therapeutics Ltd | Crispr rna molecules for improved ev-mediated delivery of cas12 rnp complexes |
| AU2026200047A1 (en) * | 2025-01-10 | 2026-07-30 | China Medical University | Central nervous system targeting pharmaceutical composition |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4090299A (en) * | 1998-05-20 | 1999-12-06 | Sdg, Inc. | Liposomal delivery complex |
| US20040241176A1 (en) * | 2000-04-27 | 2004-12-02 | Ap Cells. Inc. | Method of producing membrane vesicles |
| US20070128117A1 (en) * | 2003-02-04 | 2007-06-07 | Bracco International B.V. | Ultrasound contrast agents and process for the preparation thereof |
| JP2007295929A (ja) * | 2006-04-05 | 2007-11-15 | Geno Membrane:Kk | イヌBsep遺伝子 |
| EP2198033A4 (en) * | 2007-08-30 | 2011-05-25 | Virexx Medical Corp | ANTIGENIC COMPOSITIONS AND USE THEREOF IN THE TARGETED INTRODUCTION OF NUCLEIC ACIDS |
| AU2008303057B2 (en) * | 2007-09-24 | 2014-09-04 | The University Of Queensland | Molecular delivery vesicle |
| PT2419144T (pt) * | 2009-04-17 | 2019-09-16 | Univ Oxford Innovation Ltd | Composição para a administração de material genético |
| SG191233A1 (en) * | 2010-12-23 | 2013-07-31 | Janssen Biotech Inc | Active protease-resistant antibody fc mutants |
| DK2675474T3 (en) * | 2011-02-15 | 2019-04-23 | Vaxiion Therapeutics Llc | THERAPEUTIC COMPOSITIONS AND PROCEDURES FOR TARGETED ADMINISTRATION OF BIOACTIVE MOLECULES BY BACK-TERIAL MINICLES BASED ON ANTIBODY AND FC-CONTAINING TAR-GETING MOLECULES |
| GB201121069D0 (en) * | 2011-12-07 | 2012-01-18 | Isis Innovation | Delivery system |
| GB201121070D0 (en) * | 2011-12-07 | 2012-01-18 | Isis Innovation | composition for delivery of biotherapeutics |
| EP2983721B2 (en) * | 2013-04-12 | 2021-01-20 | Evox Therapeutics Limited | Therapeutic delivery vesicles |
| WO2015002956A1 (en) | 2013-07-01 | 2015-01-08 | Ohio State Innovation Foundation | Exosome delivery system |
| US10538570B2 (en) * | 2013-09-30 | 2020-01-21 | Northwestern University | Targeted and modular exosome loading system |
| WO2015058148A1 (en) * | 2013-10-17 | 2015-04-23 | Children's Hospital Los Angeles | Antibody dependent exosome therapy |
| WO2015143113A1 (en) * | 2014-03-20 | 2015-09-24 | Barb Ariel Cohen | Preparations of derived extracellular vesicles, assays, and methods to modify therapeutic outcomes using such preparations |
| GB2552473A (en) * | 2016-07-21 | 2018-01-31 | Evox Therapeutics Ltd | Surface decoration of extracellular vesicles |
-
2016
- 2016-07-21 GB GB1612643.5A patent/GB2552473A/en not_active Withdrawn
-
2017
- 2017-07-21 SG SG10202100598RA patent/SG10202100598RA/en unknown
- 2017-07-21 SG SG11201811152YA patent/SG11201811152YA/en unknown
- 2017-07-21 WO PCT/EP2017/068476 patent/WO2018015535A1/en not_active Ceased
- 2017-07-21 MX MX2019000863A patent/MX2019000863A/es unknown
- 2017-07-21 AU AU2017299214A patent/AU2017299214A1/en not_active Abandoned
- 2017-07-21 BR BR112019001108A patent/BR112019001108A2/pt not_active IP Right Cessation
- 2017-07-21 EP EP23192812.8A patent/EP4299137A3/en not_active Withdrawn
- 2017-07-21 CN CN201780045139.XA patent/CN109689097B/zh not_active Expired - Fee Related
- 2017-07-21 US US16/319,061 patent/US11236143B2/en not_active Expired - Fee Related
- 2017-07-21 SG SG10202100597TA patent/SG10202100597TA/en unknown
- 2017-07-21 CA CA3031183A patent/CA3031183A1/en active Pending
- 2017-07-21 US US16/319,087 patent/US20230181757A1/en not_active Abandoned
- 2017-07-21 CN CN201780045183.0A patent/CN109689098A/zh active Pending
- 2017-07-21 EP EP17749397.0A patent/EP3487529A1/en not_active Withdrawn
- 2017-07-21 JP JP2019502253A patent/JP7140743B2/ja not_active Expired - Fee Related
- 2017-07-21 JP JP2019502697A patent/JP7254016B2/ja active Active
- 2017-07-21 EP EP17749395.4A patent/EP3487528B1/en active Active
- 2017-07-21 KR KR1020197005096A patent/KR102636776B1/ko active Active
- 2017-07-21 CA CA3031186A patent/CA3031186A1/en active Pending
- 2017-07-21 SG SG11201811151PA patent/SG11201811151PA/en unknown
- 2017-07-21 KR KR1020197005093A patent/KR20190032479A/ko not_active Withdrawn
- 2017-07-21 MX MX2019000861A patent/MX2019000861A/es unknown
- 2017-07-21 BR BR112019001099A patent/BR112019001099A2/pt not_active IP Right Cessation
- 2017-07-21 WO PCT/EP2017/068486 patent/WO2018015539A1/en not_active Ceased
- 2017-07-21 AU AU2017300035A patent/AU2017300035A1/en not_active Abandoned
-
2021
- 2021-12-15 US US17/551,582 patent/US20220098267A1/en not_active Abandoned
-
2022
- 2022-05-24 JP JP2022084613A patent/JP2022117998A/ja active Pending
- 2022-12-01 JP JP2022192884A patent/JP2023026440A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Leuchowius et al. | In situ proximity ligation assay for microscopy and flow cytometry | |
| Wilhelm et al. | Intracellular and plasma membrane cholesterol labeling and quantification using filipin and GFP-D4 | |
| Bellucci et al. | The “in situ” proximity ligation assay to probe protein–protein interactions in intact tissues | |
| ES2636483T3 (es) | Métodos y sistemas para la amplificación de señal de bioensayos | |
| Wang et al. | Small quantum dots conjugated to nanobodies as immunofluorescence probes for nanometric microscopy | |
| WO2015055708A1 (en) | Sensitive qualitative bioassay using graphene oxide as analyte revealing agent | |
| Xie et al. | Application of surface‐enhanced Raman scattering in cell analysis | |
| JP6493085B2 (ja) | 蛍光色素内包樹脂粒子溶液の選択方法および濃度調整方法 | |
| JP6658330B2 (ja) | 組織切片から蛍光ナノ粒子の解離を防止する方法 | |
| CN103994911A (zh) | 一种基于同种属来源第一抗体的免疫荧光双重标记方法 | |
| Eichler et al. | Methods for Visualizing and Quantifying Cholesterol Distribution in Mammalian Cells Using Filipin and D4 Probes | |
| Kläsener et al. | Study B cell antigen receptor nano-scale organization by in situ Fab proximity ligation assay | |
| Poulard et al. | Proximity ligation assay to detect and localize the interactions of ERα with PI3-K and Src in breast cancer cells and tumor samples | |
| Barbierato et al. | Indirect immunofluorescence staining of cultured neural cells | |
| East et al. | Quantum dot–antibody conjugates via carbodiimide-mediated coupling for cellular imaging | |
| Krenacs et al. | Multiple antigen immunostaining procedures | |
| CN106644632B (zh) | 用于单层细胞平铺的人工基质 | |
| van den Akker et al. | Fluorescent nanoplastics: What steps are needed towards a representative toolkit? | |
| Hašek | Yeast fluorescence microscopy | |
| JP6524833B2 (ja) | 蛍光体集積ナノ粒子を用いたfishまたは免疫染色スライドの封入方法 | |
| Brazhnik et al. | Advanced procedure for oriented conjugation of full-size antibodies with quantum dots | |
| Leslie et al. | Going solo: measuring the motions of microtubules with an in vitro assay for TIRF microscopy | |
| Tsuboi et al. | Bioluminescence resonance energy transfer (BRET) coupled near-infrared imaging of apoptotic cells | |
| De Plano et al. | Direct conjugation of silicon nanoparticles with M13pVIII-engineered proteins to bacteria identification | |
| Johnson et al. | Fluorescence microscopy and proteomics to investigate subcellular localization, assembly, and function of the type II secretion system |